Daniel Chastain
@DBChastain
Followers
263
Following
601
Media
12
Statuses
239
Infectious diseases pharmacist | Clinical Associate Professor, UGA College of Pharmacy
Joined November 2020
Super job by my @UGAPharmacy colleague @DBChastain leading this review (FREE Open Access): Adjunctive β-lactams for Staphylococcus aureus bacteremia: a narrative review
journals.sagepub.com
Staphylococcus aureus bacteremia (SAB) remains a major clinical challenge, with persistently high mortality despite advancements in antimicrobial therapy. The e...
1
6
21
Suggested investigation of suspected immunosuppression* *Also: recurrent deep abscesses, chronic diarrhoea with weight loss, recurring infections, infection requiring prolonged antibiotic therapy, persistent rash (particularly without recent antibiotic use).
1
36
101
Thankful to have worked with @andhen25 and @GRThompsonMD in highlighting the low rates and inconsistent prescribing of PJP prophylaxis for patients on glucocorticoids ≥2 weeks in @CIDJournal
Glucocorticoids, Concomitant Immunosuppression, and PJP Prophylaxis Among U.S. Adults ✅ Just Accepted ✍️ @DBChastain 🔗 https://t.co/yP9pnsaJ54
1
3
7
The @AJHPOfficial ID themed issue was just released and we're (@stoverkr & I) excited to slowly share a brief synopsis of the included articles in this thread. First, a link to the full issue to browse the TOC is here: https://t.co/qaMOhe1ERE
#idxposts @ASHPOfficial
1
8
25
Thanks @ASP_PharmD Here's a direct link to the ID themed issue: https://t.co/qaMOhe1ERE I'll try and provide a brief recap on the full edition over @X soon! @AJHPOfficial @AJHPOfficial @stoverkr
Lots of great articles in this ID-themed issue of @AJHPOfficial @ASHPOfficial, including guest editors @BBookstaver_USC & @stoverkr. If you're into ID Rx, this issue is for you.
1
4
17
Great collab w/ @UGAPharmacy students Meg George & Tonisha Gaitor, @andhen25, and @DavidCluck2, examining climate change's impact on fungal infections, incl. increased virulence, resistance, & emerging pathogens! Thanks @TAInfDis!
journals.sagepub.com
Anthropogenic climate change, primarily driven by greenhouse gas emissions, is reshaping ecosystems and creating conditions that affect 58% of all known human i...
🌍🔥 Climate change is fueling the rise of fungal infections! Warmer temps, extreme weather & shifting ecosystems are making fungi more virulent & drug-resistant. With rising host susceptibility, the threat is growing. https://t.co/QQznCAHSRN
0
1
3
Good discussion on pros and cons of potentially shortening treatment duration for candidemia by @UGAPharmacy faculty @DBChastain. Still awaiting more data to make informed decisions on appropriate DOT. #ashp24
0
3
4
Inspired on our recent trips to Peru and Zimbabwe We have so much to learn from our Global South colleagues #GlobalHealth
@CUDeptMedicine @E_Stenehjem @paimadhu
📚Submissions open for the collection -Case Reports from the Global South: Learning from Low- to Mid-Resource Settings 🗓️ Deadline: November 28, 2025 💡 Showcase innovation,resilience, & local expertise in resource-limited settings. @andhen25
https://t.co/vpg2oEI9go
0
3
8
Looking for a PGY2 ID residency (or CC, or Peds)? Come see @UMMCPharmacy at either the SNPhA x ACCP showcase this week or at ASHP Midyear! All PGY2 programs will be at PPS!
The SNPhA x ACCP Residency Showcase - take advantage of this innovative opportunity to make purposeful connections. Learn more and register: https://t.co/8OvvIzB7qq
@SNPhA
0
2
7
Our large database analysis @TriNetX of viral and fungal infections after CAR T cell therapy is out now at @CMIJournal! With @Emily_Siegrist @andhen25 @RitaWilsonDib1 @joseandres2910 @DBChastain @chiayuchiuID et al. @OUCollegeofMed #TxID #lymsm #mmsm 🧵 https://t.co/dDERJWuR0C
clinicalmicrobiologyandinfection.org
This large database analysis aims to describe the incidence, timeline, and risk factors for viral and fungal infections after chimeric antigen receptor (CAR) T-cell therapy.
2
18
39
My beloved Cali, Colombia is hosting the 16th meeting of the Conference of the Parties to the Convention on Biological Diversity 🌿 🦠🌍 @UNBiodiversity is spotlighting how protecting our planet's biodiversity can help prevent diseases #COP16 #GlobalHealth @CUDeptMedicine
1
5
21
Thanks, @hallpharms! It was a lot of fun putting these slides together and highlighting all the fantastic work being done with SAB.
0
0
6
What a fantastic session with @andhen25 and @bryan_p_white! Appreciate @IDWeekmtg for the opportunity to watch virtually.
So excited to hear from our super ⭐️ Editor in Chief @andhen25 about optimal therapy for invasive Candidiasis 🍄 #IDWeek2024
0
0
9
Thank you so much @patricia_rdz_z! Appreciate you sharing the presentation.
#IDWeek2024 Biterapia en bacteriemia por Estafilococo aureus, en Camera 1 y Camera 2 origen endovascular está subrepresentado .8-39% no responden a monoterapia. En quien considerarla riesgo de Bacteremia persistente estratificar pacientes . Great talk @DBChastain
0
0
2
You're the best @stoverkr! Thank you so much for all your support!
Kudos to #IDWeek2024 for providing the hybrid meeting option so I could watch this 🔥🔥 session with @DBChastain and moderated by @blandman19 on the way home.
0
0
8
Well done, @ferraz_md! Congratulations!
A huge shoutout to the talented @ferraz_md for her inspiring poster and research on candidemia mortality differences by species at @IDWeekmtg 🌟 Your work is crucial in advancing our understanding and treatment of this serious infection. Bravo! 👏🦠 @CUDivofID @CUAnschutz
0
1
11
I love these two slides on the evidence for combination therapy in persistent MRSA and MSSA bacteremia. References in footer of each slide. #IDWeek2024
5
147
458
Very grateful to @SAIRABT for sharing my slides from @IDWeekmtg. Exciting to see the presentation reaching a broader audience!
0
0
2
Thanks @CalderwoodMD for sharing my slides on this important @CIDJournal paper highlighting the diversity and longitudinal trends of SAB, with subphenotypes that impact outcomes—crucial insights for personalizing therapy
Fascinating study discussed at #IDWeek2024. Four different clinical phenotypes for S aureus bacteremia. https://t.co/GdZIYGGzxz Highest mortality in A, lower mortality in B and E, microbiologic outcomes worse in C (with adjunctive rifampicin benefit seen in C).
1
1
11
@DBChastain presenting adjunctive therapies for SAB @IDWeekmtg Understanding different sub-phenotypes within MSSA and unique risk factors Amazing 🤩 talk
1
2
10